Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 553-557, March 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubin, R. C.
Right arrow Articles by Rall, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubin, R. C.
Right arrow Articles by Rall, D. P.

Uptake of Methotrexate-3H by Rabbit Kidney Slices

Robert C. Rubin, Edward S. Henderson, Ernest S. Owens and David P. Rall

Laboratory of Chemical Pharmacology and Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014

Methotrexate-3H (MTX-3H) was accumulated against a concentration gradient by renal cortical slices. This accumulation was energy dependent, inhibited by metabolic inhibitors, Diamox, and high concentrations of ouabain.

Several folic acid analogs containing the pteridine ring were inhibitors of this accumulation while certain weak organic acids were less striking inhibitors. This suggests that MTX-3H is carrier transported into cells nonspecifically as a weak organic acid and specifically as a folic acid analog.

The accumulation of MTX-3H may represent transport from blood to urine and may be clinically important in predicting drug toxicity.

Received 1/11/66. Accepted 11/ 1/66.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. Ifergan, G. Jansen, and Y. G. Assaraf
The Reduced Folate Carrier (RFC) Is Cytotoxic to Cells under Conditions of Severe Folate Deprivation: RFC AS A DOUBLE EDGED SWORD IN FOLATE HOMEOSTASIS
J. Biol. Chem., July 25, 2008; 283(30): 20687 - 20695.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.